Drug-coated balloon angioplasty for severe pulmonary vein stenosis resulting from cryoballoon ablation for atrial fibrillation. Issue 1 (July 2022)

• Record Type: Journal Article
• Authors: Yamaguchi, Koji; Wakatsuki, Tetsuzo; Matsuura, Tomomi; Matsumoto, Kazuhisa; Kawabata, Yutaka; Kadota, Muneyuki; Kusunose, Kenya; Ise, Takayuki; Yagi, Shusuke; Fukuda, Daiju; Yamada, Hirotsugu; Soeki, Takeshi; Sata, Masataka
• Is Part Of: Journal of cardiology cases. Volume 26:Issue 1(2022)
• Page Start: 35
• Page End: 38
• Publication Date: 2022-07
• Subjects: Drug-coated balloon -- Pulmonary vein stenosis -- Paclitaxel -- Cryoballoon ablation; Cardiology -- Periodicals; Cardiovascular Diseases -- Case Reports; Cardiovascular Diseases -- Periodicals; Cardiology -- Case Reports; Cardiology -- Periodicals; Cardiology; Electronic journals; Periodicals; 616.12
• DOI: 10.1016/j.jccase.2022.02.009
• Languages: English
• ISSNs: 1878-5409

Abstract

Abstract: We performed a drug-coated balloon (DCB) angioplasty for severe pulmonary vein (PV) stenosis resulting from cryoballoon ablation for atrial fibrillation. Three and fourteen months after the angioplasty, follow-up multidetector computed tomography did not show restenosis. Lesion regression was observed at 14-month follow-up. Two years after PV angioplasty with DCB, the patient was well without any symptoms. DCB angioplasty may become an alternative effective procedure for PV stenosis. Learning objective: The usefulness and safety of drug-coated balloon angioplasty for severe pulmonary vein stenosis resulting from cryoballoon ablation for atrial fibrillation was observed at 14-month follow-up.